Tumor cell survival is sustained by GSK3b in many cancer types, such as pancreatic [149], non-small-cell lung carcinoma [150], renal cell carcinoma [151], and chronic lymphocytic leukemia B cells [152]. Here, GSK3B is linked to neoplasm.